{"product_id":"ensg-vrio-analysis","title":"The Ensign Group, Inc. (ENSG): VRIO Analysis [Mar-2026 Updated]","description":"\u003cbr\u003e\u003cp\u003eUnlocking the secrets to The Ensign Group, Inc. (ENSG)'s enduring success starts here: Is their current foundation built on fleeting advantages or truly sustainable competitive power? This concise VRIO analysis strips away the noise to reveal precisely where The Ensign Group, Inc. (ENSG) creates Value, leverages Rarity, defends against Inimitability, and ensures proper Organization. Scroll down immediately to see the definitive verdict on their strategic strengths.\u003c\/p\u003e\n\n\u003cbr\u003e\u003ch2\u003eThe Ensign Group, Inc. (ENSG) - VRIO Analysis: 1. Disciplined Acquisition \u0026amp; Integration Engine\n\u003c\/h2\u003e\n\u003cp\u003eYou’re looking at The Ensign Group, Inc.’s (ENSG) core strength - their ability to buy facilities and make them significantly better, fast. This isn't just buying; it’s a repeatable, high-precision integration machine. They consistently achieve margin enhancements, often within five quarters of closing a deal.\u003c\/p\u003e\n\u003cp\u003eThe sheer pace of this engine is what sets them apart in the fragmented post-acute sector. They added 45 new operations just in 2025 so far, building on a run that includes 78 acquisitions since 2023. Honestly, few competitors can match that velocity and consistency. That’s the value proposition right there.\u003c\/p\u003e\n\u003cp\u003eHere’s the quick math on how this engine scores:\u003c\/p\u003e\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003ctd\u003eVRIO Dimension\u003c\/td\u003e\n\u003ctd\u003eAssessment\/Score\u003c\/td\u003e\n\u003ctd\u003eImplication\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eValue\u003c\/td\u003e\n\u003ctd\u003eYes\u003c\/td\u003e\n\u003ctd\u003eDrives consistent margin improvement and revenue growth.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRarity\u003c\/td\u003e\n\u003ctd\u003eYes\u003c\/td\u003e\n\u003ctd\u003eThe speed (e.g., 45 additions in 2025) and consistency of turnaround is rare.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eInimitability\u003c\/td\u003e\n\u003ctd\u003eModerate\u003c\/td\u003e\n\u003ctd\u003eRequires deep, embedded operational expertise and specific incentive alignment to copy.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOrganization\u003c\/td\u003e\n\u003ctd\u003eYes\u003c\/td\u003e\n\u003ctd\u003eHighly organized to manage the scale, evidenced by 373 operations across 17 states as of December 2025.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCompetitive Advantage\u003c\/td\u003e\n\u003ctd\u003eSustained\u003c\/td\u003e\n\u003ctd\u003eThe acquisition-expertise flywheel reinforces itself over time.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp\u003eThe operational scale supporting this engine is impressive, showing they can absorb and manage growth effectively. If onboarding takes 14+ days longer than planned for a new facility, churn risk rises, but their structure seems built for speed.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eTotal healthcare operations managed reached \u003cstrong\u003e373\u003c\/strong\u003e across \u003cstrong\u003e17\u003c\/strong\u003e states by December 2025.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e45\u003c\/strong\u003e operations were acquired during 2025 alone.\u003c\/li\u003e\n\u003cli\u003eThey have completed \u003cstrong\u003e78\u003c\/strong\u003e acquisitions since 2023.\u003c\/li\u003e\n\u003cli\u003eThe Skilled Services segment drove revenue growth, with consolidated GAAP revenue at $\u003cstrong\u003e1.30\u003c\/strong\u003e billion in Q3 2025.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThis capability is defintely their moat. It’s not just about the transaction; it’s about the operational playbook they deploy immediately after the ink dries. Finance: draft 13-week cash view by Friday.\u003c\/p\u003e\n\n\u003cbr\u003e\u003ch2\u003eThe Ensign Group, Inc. (ENSG) - VRIO Analysis: 2. Decentralized Local Leadership Model\n\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eValue: Empowers local Partner Teams to tailor care and operations to specific market needs, driving better clinical and financial outcomes.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\n\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003eSame Store Occupancy (Q2 2024): \u003cstrong\u003e80.8%\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003eSame Store Skilled Services Revenue Growth (Q2 2024): \u003cstrong\u003e6.8%\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003eGross Margin (Dec 2024): \u003cstrong\u003e15.7%\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\n\u003c\/p\u003e\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003cth\u003ePeriod\/Context\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eTotal Revenue\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$4.82 Billion USD\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e2025 (TTM)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGAAP Net Income\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$298 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eFiscal Year 2024\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOperating Margin\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e12.4%\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e2022\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTotal Healthcare Facilities Operated\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e347\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eAs of June 2025\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003cp\u003e\u003cstrong\u003eRarity: Most competitors rely on more centralized, top-down management; this level of local accountability is uncommon.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\n\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003eTotal Skilled Services Revenue (FY 2024): \u003cstrong\u003e$4.1 billion\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003e2025 Annual Earnings Guidance (Diluted EPS): \u003cstrong\u003e$6.16 to $6.34\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cstrong\u003eImitability: Difficult; it requires a deep cultural commitment and a long history of trusting local operators, which takes years to build.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\n\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003eExecutive Leadership Team Average Tenure: \u003cstrong\u003e15+ years\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003eConsecutive Years of Dividend Increase: \u003cstrong\u003e22nd\u003c\/strong\u003e (as of Dec 2024)\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cstrong\u003eOrganization: The organization is structured around this model, relying on field-centric execution rather than just a sharp central team.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\n\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003eGAAP Diluted EPS (FY 2024): \u003cstrong\u003e$5.12\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003ePortfolio Expansion Since 2023: Acquired \u003cstrong\u003e64\u003c\/strong\u003e new operations\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cstrong\u003eCompetitive Advantage: Sustained; it is deeply embedded in the company’s culture and organizational structure.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\n\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003eRevenue (2024): \u003cstrong\u003e$4.26 Billion USD\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003eRevenue Growth (2024 vs 2023): \u003cstrong\u003e14.24%\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\n\u003cbr\u003e\u003ch2\u003eThe Ensign Group, Inc. (ENSG) - VRIO Analysis: 3. Captive Real Estate Platform (Standard Bearer REIT)\n\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eValue:\u003c\/strong\u003e Provides capital flexibility, a hedge against volatile landlord-tenant dynamics, and a source of rental revenue, with \u003cstrong\u003e149\u003c\/strong\u003e owned properties as of the third quarter of 2025.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRarity:\u003c\/strong\u003e Having a captive Real Estate Investment Trust (REIT) subsidiary that actively acquires and leases properties back to the operator is a unique structural advantage.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eImitability:\u003c\/strong\u003e Difficult; establishing a fully functional, scaled REIT structure requires significant capital and regulatory navigation.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOrganization:\u003c\/strong\u003e The structure is well-integrated, with Standard Bearer generating revenue from both Ensign affiliates and third parties.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCompetitive Advantage:\u003c\/strong\u003e Sustained; this vertical integration acts as a significant structural moat.\u003c\/p\u003e\n\u003cp\u003eStandard Bearer Key Financial and Property Metrics:\u003c\/p\u003e\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003ctd\u003eMetric\u003c\/td\u003e\n\u003ctd\u003eQ4 2024 (Quarter Ended Dec 31, 2024)\u003c\/td\u003e\n\u003ctd\u003eQ3 2025 (Quarter Ended Sep 30, 2025)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eOwned Properties\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e129\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e149\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRental Revenue (Quarterly)\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$25.1 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$32.6 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRevenue from Ensign Affiliates (Quarterly)\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$20.7 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$27.6 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eStandard Bearer FFO (Quarterly)\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$15.3 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$19.3 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eStandard Bearer Revenue YoY Growth\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e14.8%\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e33.5%\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp\u003eProperty Lease Distribution for Standard Bearer:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eLeased to Ensign-affiliated operator (Q3 2025): \u003cstrong\u003e115\u003c\/strong\u003e properties.\u003c\/li\u003e\n\u003cli\u003eLeased to third-party operators (Q3 2025): \u003cstrong\u003e35\u003c\/strong\u003e properties.\u003c\/li\u003e\n\u003cli\u003eLeased to Ensign-affiliated operator (Q4 2024): \u003cstrong\u003e97\u003c\/strong\u003e properties.\u003c\/li\u003e\n\u003cli\u003eLeased to third-party operators (Q4 2024): \u003cstrong\u003e33\u003c\/strong\u003e properties.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eStandard Bearer Intercompany Expense Details for Three Months Ended March 31, 2025:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eManagement fee from intercompany agreements: \u003cstrong\u003e$1.7 million\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eInterest from intercompany agreements: \u003cstrong\u003e$7.0 million\u003c\/strong\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cbr\u003e\u003ch2\u003eThe Ensign Group, Inc. (ENSG) - VRIO Analysis: 4. Operational Turnaround Expertise\n\u003c\/h2\u003e\n\n\u003ch3\u003eValue\u003c\/h3\u003e\n\u003cp\u003eDirectly translates underperforming assets into profitable ones by improving key metrics like skilled mix days (at \u003cstrong\u003e32.4%\u003c\/strong\u003e in Q2 2025) and occupancy (at \u003cstrong\u003e83.0%\u003c\/strong\u003e in Q3 2025).\u003c\/p\u003e\n\u003cp\u003eFurther operational metrics demonstrating value creation:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eSame Store Occupancy in Q2 2025 reached \u003cstrong\u003e82.1%\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eTransitioning Facilities Occupancy in Q3 2025 reached \u003cstrong\u003e84.4%\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eSame Facilities Skilled Services Revenue in Q3 2025 increased by \u003cstrong\u003e6.6%\u003c\/strong\u003e over the prior year quarter.\u003c\/li\u003e\n\u003cli\u003eTransitioning Facilities Skilled Services Revenue in Q3 2025 increased by \u003cstrong\u003e10.3%\u003c\/strong\u003e over the prior year quarter.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003ePeriod\/Segment\u003c\/th\u003e\n\u003cth\u003eData Point\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eOccupancy Percentage\u003c\/td\u003e\n\u003ctd\u003eQ3 2025 Same Facilities\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e83.0%\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSkilled Mix by Nursing Days\u003c\/td\u003e\n\u003ctd\u003eQ2 2025\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e32.4%\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAdjusted Diluted EPS\u003c\/td\u003e\n\u003ctd\u003eQ3 2025\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$1.64\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eConsolidated Revenue\u003c\/td\u003e\n\u003ctd\u003eQ2 2025\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$1.23 billion\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTotal Facilities at Period End\u003c\/td\u003e\n\u003ctd\u003eQ2 2025\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e348\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003ch3\u003eRarity\u003c\/h3\u003e\n\u003cp\u003eWhile many operators can manage well-run facilities, the consistent, rapid improvement of struggling ones is a specialized, rare skill.\u003c\/p\u003e\n\u003cp\u003eContextual data points:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eThe company has completed \u003cstrong\u003e78\u003c\/strong\u003e acquisitions since 2023.\u003c\/li\u003e\n\u003cli\u003eIn Q3 2025, Ensign acquired \u003cstrong\u003e22\u003c\/strong\u003e new operations across six states.\u003c\/li\u003e\n\u003cli\u003eHistorically, some acquired facilities had occupancy rates as low as \u003cstrong\u003e30%\u003c\/strong\u003e at the time of acquisition.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eImitability\u003c\/h3\u003e\n\u003cp\u003eDifficult; it relies on proprietary processes for clinical quality improvement and cost control that are not easily reverse-engineered.\u003c\/p\u003e\n\u003cp\u003eEvidence of successful clinical improvement:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003ePercentage of 1-star facilities reduced from \u003cstrong\u003e41.3%\u003c\/strong\u003e in 2009 to \u003cstrong\u003e17.2%\u003c\/strong\u003e in May 2025.\u003c\/li\u003e\n\u003cli\u003eAdjusted EBITDAR grew from \u003cstrong\u003e$87 million\u003c\/strong\u003e to a projected \u003cstrong\u003e$706 million\u003c\/strong\u003e over the same period (2009 to 2025).\u003c\/li\u003e\n\u003cli\u003eOne facility (River Park Post Acute) advanced from a 3-star to a 5-star rating post-acquisition.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eOrganization\u003c\/h3\u003e\n\u003cp\u003eThis expertise is clearly deployed across all new acquisitions, showing it is a core, repeatable process.\u003c\/p\u003e\n\u003cp\u003eDeployment statistics:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003e29.9%\u003c\/strong\u003e of its skilled nursing operations have been operated for less than three years (as of Q2 2025).\u003c\/li\u003e\n\u003cli\u003eSignificant enhancements in skilled mix revenue, EBITDAR margins, and occupancy are typically achieved within just \u003cstrong\u003efive quarters\u003c\/strong\u003e of acquisition.\u003c\/li\u003e\n\u003cli\u003eThe company has raised its 2025 earnings guidance to \u003cstrong\u003e$6.48-$6.54\u003c\/strong\u003e per diluted share.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eCompetitive Advantage\u003c\/h3\u003e\n\u003cp\u003eSustained; it is the core value proposition applied to every new deal.\u003c\/p\u003e\n\u003cp\u003eLong-term performance indicators:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eTotal shareholder return over the past decade: \u003cstrong\u003e1,525%\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eTotal shareholder return since 2007 IPO: \u003cstrong\u003e4,111%\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eRevenue CAGR from 2014 to 2024: \u003cstrong\u003e15%\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eAdjusted EBITDAR CAGR from 2014 to 2024: \u003cstrong\u003e16%\u003c\/strong\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cbr\u003e\u003ch2\u003eThe Ensign Group, Inc. (ENSG) - VRIO Analysis: 5. Geographic Clustering Strategy\n\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eValue:\u003c\/strong\u003e Reduces fixed costs (staffing, purchasing, compliance) by concentrating operations in specific regions, enhancing operating leverage. The cluster model incentivizes sharing best practices, with compensation linked to the cluster's clinical and financial success.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRarity:\u003c\/strong\u003e While geographic presence is common, the deliberate strategy of clustering for cost efficiency is a specific, less common tactical approach. The company has a presence in 17 states as of Q3 2025.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eImitability:\u003c\/strong\u003e Moderate; competitors can copy the locations, but replicating the established cost-sharing infrastructure takes time. The company has 369 healthcare operations as of Q3 2025.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOrganization:\u003c\/strong\u003e Management explicitly focuses on clustering in key markets like Texas and California to maximize this benefit. Recent activity includes an 11-building portfolio acquisition in California during Q3 2025.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCompetitive Advantage:\u003c\/strong\u003e Temporary; it can be copied by aggressive competitors over time, though the first-mover advantage helps.\u003c\/p\u003e\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eClustering Metric\u003c\/th\u003e\n\u003cth\u003eData Point\u003c\/th\u003e\n\u003cth\u003eReference Period\/Note\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eStates with Operations\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e17\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eAs of Q3 2025\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTotal Healthcare Operations\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e369\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eAs of Q3 2025\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCalifornia Portfolio Growth\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e11-building\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eAcquired portfolio in Q3 2025\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTexas Facility Acquisitions\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e5\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eOperations acquired effective July 1, 2022\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp\u003eThe company's strategy involves strengthening existing operational markets and clusters, particularly in Texas.\u003c\/p\u003e\n\n\u003cbr\u003e\u003ch2\u003eThe Ensign Group, Inc. (ENSG) - VRIO Analysis: 6. Focus on High-Acuity\/Skilled Mix Revenue\n\u003c\/h2\u003e\n\n\u003cp\u003e\u003cstrong\u003eValue:\u003c\/strong\u003e Higher acuity patients generate significantly better reimbursement rates (Medicare\/Managed Care), driving higher margins compared to lower-acuity, long-term Medicaid patients.\u003c\/p\u003e\n\n\u003cp\u003eThe shift in revenue mix highlights the focus on higher-reimbursing streams:\u003c\/p\u003e\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003ePayor Source\u003c\/th\u003e\n\u003cth\u003eYear Ended Dec 31, 2023 Revenue ($)\u003c\/th\u003e\n\u003cth\u003e% of Total Service Revenue (2023)\u003c\/th\u003e\n\u003cth\u003eYear Ended Dec 31, 2024 Revenue ($)\u003c\/th\u003e\n\u003cth\u003e% of Total Service Revenue (2024)\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eMedicaid\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e1,459,449,000\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e39.4%\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e1,682,344,000\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e39.7%\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMedicare\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e985,749,000\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e26.6%\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e1,055,226,000\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e24.9%\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTotal Medicaid and Medicare\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e2,690,861,000\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e72.6%\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e3,004,308,000\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e70.9%\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eManaged Care\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e666,129,000\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e18.0%\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e789,643,000\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e18.6%\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePrivate and Other\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e351,081,000\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e9.4%\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e443,574,000\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e10.5%\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTotal Service Revenue\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e3,708,071,000\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e100.0%\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e4,237,525,000\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e100.0%\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003cp\u003e\u003cstrong\u003eRarity:\u003c\/strong\u003e Many competitors are more reliant on lower-paying, stable Medicaid revenue; Ensign’s focus on the higher-paying skilled segment is a strategic differentiator.\u003c\/p\u003e\n\n\u003cp\u003eSkilled Mix as a percentage of total skilled nursing days demonstrates the focus on higher acuity:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eSkilled Mix Days Percentage for the year ended December 31, 2023: \u003cstrong\u003e30.4%\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eSkilled Mix Days Percentage for the year ended December 31, 2024: \u003cstrong\u003e29.9%\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eMedicaid Days Percentage for the year ended December 31, 2023: \u003cstrong\u003e58.6%\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eMedicaid Days Percentage for the year ended December 31, 2024: \u003cstrong\u003e59.4%\u003c\/strong\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eRecent performance in skilled services revenue and days for Same Facilities and Transitioning Facilities (Q3 2025 vs. prior year quarter):\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eTotal Skilled Services Revenue: Increase of \u003cstrong\u003e19.9%\u003c\/strong\u003e to \u003cstrong\u003e$1.24 billion\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eSame Facilities Skilled Days: Increase of \u003cstrong\u003e5.1%\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eTransitioning Skilled Days: Increase of \u003cstrong\u003e10.9%\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eSame Facilities Medicare Revenue: Improvement of \u003cstrong\u003e10.0%\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eTransitioning Facilities Managed Care Revenue: Improvement of \u003cstrong\u003e24.3%\u003c\/strong\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cstrong\u003eImitability:\u003c\/strong\u003e Moderate; it requires clinical infrastructure and strong relationships with acute care hospitals (referral sources).\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eOrganization:\u003c\/strong\u003e The company’s success in driving skilled mix days shows management is organized to prioritize and capture this higher-value business.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eManaged Care Revenue for the quarter ended December 31, 2023, increased by \u003cstrong\u003e12.3%\u003c\/strong\u003e over the prior year's quarter.\u003c\/li\u003e\n\u003cli\u003eManaged Care Census for the quarter ended December 31, 2023, increased by \u003cstrong\u003e3.5%\u003c\/strong\u003e over the prior year quarter.\u003c\/li\u003e\n\u003cli\u003eSince spinning off Pennant Group in 2019, Adjusted EPS grew by \u003cstrong\u003e168%\u003c\/strong\u003e with a Compound Annual Growth Rate of \u003cstrong\u003e28%\u003c\/strong\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cstrong\u003eCompetitive Advantage:\u003c\/strong\u003e Sustained; as long as they maintain superior clinical quality, referral sources will favor them for complex patients.\u003c\/p\u003e\n\n\u003cbr\u003e\u003ch2\u003eThe Ensign Group, Inc. (ENSG) - VRIO Analysis: 7. Strong Liquidity Position\n\u003c\/h2\u003e\n\u003ch3\u003eValue\u003c\/h3\u003e\n\u003cp\u003eLiquidity was strong with approximately \u003cstrong\u003e$443.7 million\u003c\/strong\u003e in cash and cash equivalents as of September 30, 2025. This cash position, combined with \u003cstrong\u003e$592.6 million\u003c\/strong\u003e of available capacity under its line-of-credit, provides over \u003cstrong\u003e$1 billion\u003c\/strong\u003e in 'dry powder' for strategic growth execution.\u003c\/p\u003e\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eAmount (As of Q3 2025)\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eCash and Cash Equivalents\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$443.7 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAvailable Line-of-Credit Capacity\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$592.6 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCash Flow from Operations (9 Months Ended 9\/30\/2025)\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$381.0 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDebt-to-Equity Ratio\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e0.07\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCurrent Ratio \/ Quick Ratio\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e1.46\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003ch3\u003eRarity\u003c\/h3\u003e\n\u003cp\u003eThe liquidity supports a high-volume M\u0026amp;A strategy, evidenced by the addition of \u003cstrong\u003e22\u003c\/strong\u003e new operations during Q3 2025, bringing the 2025 total to \u003cstrong\u003e45\u003c\/strong\u003e acquisitions year-to-date.\u003c\/p\u003e\n\u003ch3\u003eImitability\u003c\/h3\u003e\n\u003cp\u003eThe strong cash position is a result of recent operational performance, as seen by the increase in annual revenue guidance to \u003cstrong\u003e$5.05 billion\u003c\/strong\u003e to \u003cstrong\u003e$5.07 billion\u003c\/strong\u003e for FY 2025.\u003c\/p\u003e\n\u003ch3\u003eOrganization\u003c\/h3\u003e\n\u003cp\u003eThe finance function maintains this buffer while funding growth, demonstrated by the continued payment of a quarterly cash dividend of \u003cstrong\u003e$0.0625 per share\u003c\/strong\u003e. The company also raised its annual 2025 earnings guidance to between \u003cstrong\u003e$6.48\u003c\/strong\u003e to \u003cstrong\u003e$6.54\u003c\/strong\u003e per diluted share.\u003c\/p\u003e\n\u003ch3\u003eCompetitive Advantage\u003c\/h3\u003e\n\u003cp\u003eThe lease-adjusted net debt-to-EBITDA ratio stood at \u003cstrong\u003e1.86x\u003c\/strong\u003e after significant investments during the first nine months of 2025.\u003c\/p\u003e\n\n\u003cbr\u003e\u003ch2\u003eThe Ensign Group, Inc. (ENSG) - VRIO Analysis: 8. Diversified Post-Acute Service Offering\n\u003c\/h2\u003e\n\n\u003cp\u003e\u003cstrong\u003eValue:\u003c\/strong\u003e Allows the company to capture patients across the entire continuum - from acute rehab to senior living - and manage transitions internally.\u003c\/p\u003e\n\u003cp\u003eThe diversified offering supports significant financial scale, as evidenced by the consolidated GAAP and adjusted revenue for the third quarter of 2025 reaching \u003cstrong\u003e$1.30 billion\u003c\/strong\u003e. Total skilled services revenue for the same period was \u003cstrong\u003e$1.24 billion\u003c\/strong\u003e.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eRarity:\u003c\/strong\u003e While many offer SNF and therapy, the integration of senior living (in \u003cstrong\u003e31\u003c\/strong\u003e operations) and ancillary services like mobile x-ray is more comprehensive.\u003c\/p\u003e\n\u003cp\u003eThe portfolio scale demonstrates the breadth of operations supporting this diversification. As of the second quarter of 2024, Ensign’s portfolio consisted of \u003cstrong\u003e312\u003c\/strong\u003e healthcare operations, with \u003cstrong\u003e29\u003c\/strong\u003e of those including senior living operations. By the end of 2024, this grew to \u003cstrong\u003e334\u003c\/strong\u003e healthcare operations, including \u003cstrong\u003e30\u003c\/strong\u003e with senior living services.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eImitability:\u003c\/strong\u003e Moderate; building out ancillary services requires capital investment and specialized operational teams.\u003c\/p\u003e\n\u003cp\u003eThe Standard Bearer segment, which includes owned real estate assets leased to operations, demonstrates a growing revenue stream that supports the overall structure:\u003c\/p\u003e\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003ctd\u003eMetric\u003c\/td\u003e\n\u003ctd\u003eQ3 2025 Amount\u003c\/td\u003e\n\u003ctd\u003eQ4 2023 Amount\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eStandard Bearer Revenue (Quarterly)\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$32.6 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$21.9 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eYear-over-Year Growth (Q3 2025 vs Q3 2024)\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003e33.5%\u003c\/strong\u003e increase\u003c\/td\u003e\n\u003ctd\u003eN\/A\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003cp\u003e\u003cstrong\u003eOrganization:\u003c\/strong\u003e The structure supports multiple service lines across its facilities, increasing revenue per patient day potential.\u003c\/p\u003e\n\u003cp\u003eThe organizational structure facilitates growth across payor sources and service lines:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eSame Facilities and Transitioning Facilities occupancy rates for Q3 2025 were \u003cstrong\u003e83.0%\u003c\/strong\u003e and \u003cstrong\u003e84.4%\u003c\/strong\u003e, respectively.\u003c\/li\u003e\n\u003cli\u003eSame Facilities and Transitioning Facilities skilled services revenue increased by \u003cstrong\u003e6.6%\u003c\/strong\u003e and \u003cstrong\u003e10.3%\u003c\/strong\u003e, respectively, over the prior year quarter (Q3 2025).\u003c\/li\u003e\n\u003cli\u003eManaged care revenue for Same Facilities and Transitioning Facilities improved by \u003cstrong\u003e7.1%\u003c\/strong\u003e and \u003cstrong\u003e24.3%\u003c\/strong\u003e, respectively, from the prior year quarter (Q3 2025).\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cstrong\u003eCompetitive Advantage:\u003c\/strong\u003e Temporary; service lines can be added by competitors, but integration takes time.\u003c\/p\u003e\n\u003cp\u003eThe company projects continued financial expansion based on its current portfolio and growth strategy:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eAnnual revenue guidance for 2025 is set between \u003cstrong\u003e$4.83 billion\u003c\/strong\u003e and \u003cstrong\u003e$4.91 billion\u003c\/strong\u003e (initial guidance) or \u003cstrong\u003e$5.05 billion\u003c\/strong\u003e to \u003cstrong\u003e$5.07 billion\u003c\/strong\u003e (raised guidance).\u003c\/li\u003e\n\u003cli\u003eThe midpoint of the raised 2025 earnings guidance represents an increase of \u003cstrong\u003e18.4%\u003c\/strong\u003e over 2024 results.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cbr\u003e\u003ch2\u003eThe Ensign Group, Inc. (ENSG) - VRIO Analysis: 9. Market Position as a High-Quality, Low-Cost Provider\n\u003c\/h2\u003e\n\n\u003cp\u003e\u003cstrong\u003eValue:\u003c\/strong\u003e This dual positioning attracts both high-reimbursing managed care payers (due to quality) and cost-conscious state\/federal programs (due to efficiency).\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eRarity:\u003c\/strong\u003e Achieving both high quality and low cost simultaneously is the holy grail in healthcare and is rarely sustained.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eImitability:\u003c\/strong\u003e Difficult; low cost often compromises quality, so achieving both requires the unique operational efficiencies mentioned above.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eOrganization:\u003c\/strong\u003e The decentralized model and focus on clinical outcomes are organized to support this dual mandate.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCompetitive Advantage:\u003c\/strong\u003e Sustained; this reputation, built over two decades, is a powerful intangible asset.\u003c\/p\u003e\n\n\u003cp\u003eThe company's ability to maintain competitive margins while serving a high percentage of government-funded patients illustrates this positioning:\u003c\/p\u003e\n\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003ePeriod Ended Q4 2023\u003c\/th\u003e\n\u003cth\u003ePeriod Ended Q4 2024\u003c\/th\u003e\n\u003cth\u003eLatest TTM (as of Nov 2025)\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eOperating Margin\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e7.53%\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e9.26%\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e9.17%\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMedicaid Revenue (% of Total)\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e39.5%\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e40.4%\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eN\/A\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003cp\u003eRecent financial performance highlights margin durability:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eNet Profit Margin: \u003cstrong\u003e6.8%\u003c\/strong\u003e (Latest) vs \u003cstrong\u003e5.8%\u003c\/strong\u003e (Last Year).\u003c\/li\u003e\n\u003cli\u003e2025 Revenue Guidance Midpoint: Between \u003cstrong\u003e$4.83 billion\u003c\/strong\u003e and \u003cstrong\u003e$4.91 billion\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eEarnings Per Share (Adjusted) for the year ended December 31, 2024: \u003cstrong\u003e$5.50\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eEarnings Per Share (Adjusted) for the year ended December 31, 2023: \u003cstrong\u003e$4.77\u003c\/strong\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eFinance: Cash \u0026amp; Cash Equivalents as of the last reported quarter were \u003cstrong\u003e$506.31 million\u003c\/strong\u003e.\u003c\/p\u003e","brand":"dcf.fm","offers":[{"title":"Default Title","offer_id":45516158206101,"sku":"ensg-vrio-analysis","price":7.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0630\/5189\/0837\/files\/ensg-vrio-analysis.png?v=1740222248","url":"https:\/\/dcf-model.com\/fr\/products\/ensg-vrio-analysis","provider":"AI-Powered Discounted Cash Flow Model Templates","version":"1.0","type":"link"}